About Kate Therapeutics
Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
San Diego, United States
Year Founded
2020
Team Size
11-50
Corporate Status
Acquired by Novartis
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
katetherapeutics.com
Domain Registered Date
Sep 5, 2020
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $51,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
katetherapeutics.com
- Milestone
Company founded
San Diego, United States
Investors & Backers
OUP (Osage University Partners)
UF Innovate Ventures
Versant Ventures
Westlake Village BioPartners
Funding History
Series-A
· Jun 8, 2023
$51,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026